Omnipresent - Content updates - EMG-Health

Updating the treatment algorithm for metastatic melanoma

14 Jun 2016 Hematology Microbiology & Infectious Diseases

Phase 3 LUX-H&N1 trial: Afatinib versus methotrexate for head and neck squamous cell carcinoma

25 May 2016 Cardiology Reproductive Health Allergy & Immunology Gastroenterology Neurology Nephrology Hepatology Rheumatology Pharma Microbiology & Infectious Diseases

Pathophysiology and treatment of hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS)

19 Apr 2016 Cardiology Reproductive Health Innovations Respiratory Allergy & Immunology Gastroenterology Neurology Diabetes Nephrology Dermatology Hematology Hepatology Interventional Cardiology Rheumatology Microbiology & Infectious Diseases

Therapeutic advances in immune checkpoint inhibitors for head and neck cancers

05 Feb 2016 Oncology Hematology Microbiology & Infectious Diseases

LUX-Lung 7: Phase 2b trial of afatinib versus gefitinib for EGFR-mutated lung cancer in first-line

04 Feb 2016 Reproductive Health Respiratory Allergy & Immunology Gastroenterology Urology Diabetes Nephrology Dermatology Microbiology & Infectious Diseases

Quality of life and new therapeutic options for metastatic castration-resistant prostate cancer

04 Feb 2016 Respiratory Rheumatology Microbiology & Infectious Diseases